Drugs, Medical Devices, Biologics Archives - Page 27 of 38

Buying and Selling Prioritized Regulatory Review: The Market for Priority Review Vouchers as Quasi-Intellectual Property (Open Access)
Gallery
Buying and Selling Prioritized Regulatory Review: The Market for Priority Review Vouchers as Quasi-Intellectual Property (Open Access)

Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Journal 73.3, Publications

Buying and Selling Prioritized Regulatory Review: The Market for Priority Review Vouchers as Quasi-Intellectual Property (Open Access)

Food and Drug Law Journal | Volume 73 | Number 3

Buying and Selling Prioritized Regulatory Review: The Market for Priority Review Vouchers as Quasi-Intellectual Property (Open Access)admin2021-07-22T15:40:30-04:00

Obsolete to Useful to Obsolete Once Again: A History of Section 507 of the Food, Drug, and Cosmetic Act
Gallery
Obsolete to Useful to Obsolete Once Again: A History of Section 507 of the Food, Drug, and Cosmetic Act

Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Journal 73.3, Publications

Obsolete to Useful to Obsolete Once Again: A History of Section 507 of the Food, Drug, and Cosmetic Act

Food and Drug Law Journal | Volume 73 | Number 3

Obsolete to Useful to Obsolete Once Again: A History of Section 507 of the Food, Drug, and Cosmetic Actadmin2021-04-21T10:51:16-04:00

Facilitating Competition and Innovation Isn’t Easy: FDA’s Latest Hearing On Biologics
Gallery
Facilitating Competition and Innovation Isn’t Easy: FDA’s Latest Hearing On Biologics

Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update EXTRA, Update Magazine

Facilitating Competition and Innovation Isn’t Easy: FDA’s Latest Hearing On Biologics

Update Magazine Extra

Facilitating Competition and Innovation Isn’t Easy: FDA’s Latest Hearing On Biologicsadmin2019-01-28T12:47:57-05:00

Guidance on Guidance: FDA, DOJ, and Enforcement
Gallery
Guidance on Guidance: FDA, DOJ, and Enforcement

Drugs, Medical Devices, Biologics, Food, Dietary Supplements, Cosmetics, General Webinars, On-demand Webinar, Tobacco Products, Webinars Homepage

Guidance on Guidance: FDA, DOJ, and Enforcement

Recorded August 21, 2018 | On-Demand Webinar

Guidance on Guidance: FDA, DOJ, and Enforcementadmin2024-07-19T10:05:34-04:00

Real World Evidence: Implications and Challenges for Medical Product Communications in an Evolving Regulatory Landscape
Gallery
Real World Evidence: Implications and Challenges for Medical Product Communications in an Evolving Regulatory Landscape

Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update August/September 2018, Update Magazine